Interferon-alpha 2a/Ribavirin versus interferon-alpha 2a alone for the retreatment of hepatitis C patients who relapse after a standard course of interferon

New Zealand Medical Journal

Volumn 114, Issue 1128, 2001, Pages 103-104

  Chapman, Bruce A ^b   Stace, Nigel H ^b   Edgar, Christine L ^b   Bartlett, Sharee E ^b   Frampton, Christopher M A ^b   Scahill, Shane L ^b   Jennings, Lance C ^b  

^a CHRISTCHURCH HOSPITAL   (New Zealand)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA2A INTERFERON; INTERFERON; RIBAVIRIN; VIRUS RNA; ANTIVIRUS AGENT;

ADULT; ARTICLE; CLINICAL ARTICLE; DEPRESSION; DOSE RESPONSE; DRUG EFFICACY; FATIGUE; FEMALE; HEADACHE; HEPATITIS C; HUMAN; LIVER BIOPSY; MALE; MYALGIA; NAUSEA; RECURRENT INFECTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TREATMENT OUTCOME; CLASSIFICATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG ADMINISTRATION; DRUG COMBINATION; GENOTYPE; HEPATITIS C VIRUS; ISOLATION AND PURIFICATION; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; RETREATMENT; VIROLOGY;

ADULT; ANTIVIRAL AGENTS; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; FEMALE; GENOTYPE; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; INTERFERON ALFA-2A; MALE; RECURRENCE; RETREATMENT; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RIBAVIRIN; RNA, VIRAL;

EID: 0035937214     PISSN: 00288446     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Alter MJ. Epidemiology of hepatitis C. Hepatology 1997; 26: Supp 1:62s-5s.
2. Poynard T, Leroy V, Cohard M et al. Meta-analysis of interferon randomised trials in the treatment of viral hepatitis: effects of dose and duration. Hepatology 1996; 24: 778-89.
3. Poynard T, Marcellin P, Lee SS et al. Randomised trial of interferon 2b plus ribavirin for 48 weeks or for 24 weeks versus interferon 2b plus placebo for 48 weeks for the treatment of chronic infection with hepatitis C virus. Lancet 1998; 352: 1426-32.
4. McHutchison JG, Gordon SC, Schiffer ER et al. Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. N Engl J Med 1998; 339: 1485-92.
5. Brillianti S, Miglioli M, Barbara L. Combination antiviral therapy with ribavirin and interferon alfa in interferon alfa relapsers and non- responders. J Hepatol 1995; 23: 13-6.
6. Bellobuono A, Mondazzi L, Silini E et al. Ribavirin and interferon-alpha combination J Virol Hepatol 1997; 4: 185-91.
7. Davis GL, Esteban-Mur R, Vindo R et al. Interferon alpha -2b alone or in combination with ribavirin for the treatment of relapse of chronic hepatitis C. N Engl J Med 1998; 339: 1493-9.
8. Schalm SW, Hansen BE, Chemello L et al. Ribavirin enhances the efficacy but not the adverse effects of interferon in chronic hepatitis C. Meta-analysis of the individual patient data from European centres. J Hepatol 1997; 26: 961-66.
9. Shibata M, Morishima T, kudo T et al. Serum hepatitis C virus sequence in post transfusion non-A non-B hepatitis. Blood 1991; 77: 1157-60.
10. Cooper A, Croxson M. An unusual strain of hepatitis C virus in New Zealand. NZ Med J 1993; 106: 199-202.
11. DiDomenico N, Link H, Knobel R et al. COBAS AMPLICOR™: a fully automated DNA amplification and detection system for routine diagnostic PCR. Clin Chem 1996; 42: 1915-23.
12. Simmonds P, Alberti A, Alter HJ et al. A proposed system for the nomenclature of hepatitis C virus genotypes. Hepatology 1994; 19: 1321-4.
13. Enonmoto N, Takada A, Nakao T, Date T. There are two major types of hepatitis C virus in Japan. Biochem Biophys Res Commun 1990; 170: 1021-5.
14. Styver L, Rossau R, Wyseur A et al. Typing of hepatitis C virus isolates and characterisation of new subtypes using a line probe assay. J Gen Virol 1993; 74: 1093-102.
15. Chemello L, Cavalletto L, Donada C et al. Efficacy of a second cycle of interferon therapy in patients with chronic hepatitis C. Gastroenterology 1997; 113: 16544-59.
16. Camma C, Guinta M, Chemello L et al. Hepatitis C: Interferon retreatment of relapsers. A meta- analysis of Individual Patient Data. Hepatology 1999; 30: 801-7.